S1 Risankizumab Versus Ustekinumab in Patients With Moderate to Severe Crohn’s Disease: Results From the Phase 3B SEQUENCE Trial

Author:

Peyrin-Biroulet Laurent1,Chapman Casey2,Colombel Jean-Frederic3,Caprioli Flavio4,D’Haens Geert5,Ferrante Marc6,Schreiber Stefan7,Atreya Raja8,Danese Silvio9,Lindsay James O.10,Bossuyt Peter11,Siegmund Britta12,Irving Peter13,Panaccione Remo14,Neimark Ezequiel15,Wallace Kori15,Anschutz Toni15,Kligys Kristina15,Duan W. Rachel15,Pivorunas Valerie15,Huang Xiu15,Berg Sofie15,Shu Lei15,Dubinsky Marla C.16

Affiliation:

1. Nancy University Hospital, Vandoeuvre-les-Nancy, France;

2. GI Alliance, United States;

3. Icahn School of Medicine at Mount Sinai, New York, United States;

4. UNIMI, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy;

5. Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam, Netherlands;

6. University Hospitals Leuven, KU Leuven, Belgium;

7. University Hospital Schleswig-Holstein, Christian Albrechts University, Kiel, Germany, Kiel, Germany;

8. University of Erlangen–Nuremberg, Erlangen, Germany;

9. Vita-Salute San Raffaele University and IRCCS San Raffaele Hospital, Milano, Italy;

10. Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom;

11. Imelda General Hospital, Bonheiden, Belgium;

12. Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany;

13. Guy’s and St Thomas’ NHS Foundation, London, United Kingdom;

14. University of Calgary, Calgary, AB, Canada, Calgary, Canada;

15. AbbVie, Chicago, Illinois, United States;

16. Mt Sinai Kravis Children’s Hospital, New York, New York, United States.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3